Twist Bioscience Corporation (TWST) Stock Overview
Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.
Twist Bioscience Corporation (TWST)
Key Financials
Key Financials
Market Cap
11.6B
P/E Ratio
-80.94
EPS (TTM)
$-2.22
ROE
-0.30%
TWST Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Twist Bioscience Corporation (NASDAQ: TWST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Twist Bioscience Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TWST on the NASDAQ shows an RSI of 72.77, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $54.55 for the NASDAQ listing.
Key metrics behind Twist Bioscience Corporation's NASDAQ-traded stock include a P/E ratio of -80.94 and a market capitalization of 11.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TWST on the NASDAQ.